We have located links that may give you full text access.
Contraceptive uptake among gender-expansive individuals in the HER Salt Lake Contraceptive Initiative.
Contraception 2024 April 5
OBJECTIVES: We examined differences in contraceptive uptake and discontinuation between gender-expansive individuals and cis-women in the HER Salt Lake Contraceptive Initiative.
STUDY DESIGN: We used self-reported survey data to assess associations between gender identity, contraceptive uptake, and discontinuation.
RESULTS: Of participants (n=4,289), 178/4289(4%) identified as gender-expansive with 157/178(88%) reporting recent sexual activity with men. Selection of IUD or Implant was most common, with 109/178(61%) of gender-expansive individuals choosing these options. We observed similar methods selected (p=0.2) and discontinuation rates at three years between participants (OR: 0.93, p=0.8).
CONCLUSION: Gender-expansive individuals had similar method selection and discontinuation rates as cis-women.
STUDY DESIGN: We used self-reported survey data to assess associations between gender identity, contraceptive uptake, and discontinuation.
RESULTS: Of participants (n=4,289), 178/4289(4%) identified as gender-expansive with 157/178(88%) reporting recent sexual activity with men. Selection of IUD or Implant was most common, with 109/178(61%) of gender-expansive individuals choosing these options. We observed similar methods selected (p=0.2) and discontinuation rates at three years between participants (OR: 0.93, p=0.8).
CONCLUSION: Gender-expansive individuals had similar method selection and discontinuation rates as cis-women.
Full text links
Related Resources
Trending Papers
Drug-Induced Myocardial Infarction: A Review of Pharmacological Triggers and Pathophysiological Mechanisms.Journal of Cardiovascular Development and Disease 2024 December 18
Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes.Journal of Internal Medicine 2024 December 31
Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction (Version 3: Revised May 20th, 2024).Clinical and Experimental Nephrology 2025 January 3
The PRECISE trial: How should patients with chest pain be tested?Cleveland Clinic Journal of Medicine 2024 November 1
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app